News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,436 Results
Type
Article (41188)
Company Profile (250)
Press Release (664998)
Multimedia
Podcasts (56)
Webinars (12)
Section
Business (206664)
Career Advice (2125)
Deals (35849)
Drug Delivery (102)
Drug Development (81614)
Employer Resources (175)
FDA (16263)
Job Trends (14956)
News (348946)
Policy (32963)
Tag
Academia (2591)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49784)
ALS (91)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (126)
Approvals (16261)
Artificial intelligence (257)
Autoimmune disease (23)
Automation (16)
Bankruptcy (366)
Best Places to Work (11692)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (280)
Cancer (2270)
Cardiovascular disease (174)
Career advice (1779)
Career pathing (30)
CAR-T (151)
Cell therapy (427)
Cervical cancer (19)
Clinical research (66379)
Collaboration (839)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2627)
CRISPR (40)
C-suite (246)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (20)
Depression (46)
Diabetes (271)
Diagnostics (6406)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (101)
Drug shortages (27)
Duchenne muscular dystrophy (96)
Earnings (87726)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (113435)
Executive appointments (737)
FDA (17528)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (756)
Gene editing (104)
Generative AI (19)
Gene therapy (307)
GLP-1 (725)
Government (4514)
Grass and pollen (4)
Guidances (67)
Healthcare (18998)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2770)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (333)
IPO (16649)
IRA (40)
Job creations (3674)
Job search strategy (1508)
Kidney cancer (10)
Labor market (38)
Layoffs (473)
Leadership (18)
Legal (8034)
Liver cancer (75)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (316)
MASH (69)
Medical device (13468)
Medtech (13473)
Mergers & acquisitions (19744)
Metabolic disorders (694)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1937)
NextGen: Class of 2025 (6572)
Non-profit (4519)
Now hiring (39)
Obesity (370)
Opinion (213)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (235)
Patient recruitment (112)
Peanut (46)
People (58233)
Pharmaceutical (65)
Pharmacy benefit managers (20)
Phase I (20683)
Phase II (29224)
Phase III (21788)
Pipeline (1208)
Policy (142)
Postmarket research (2606)
Preclinical (8798)
Press Release (66)
Prostate cancer (107)
Psychedelics (33)
Radiopharmaceuticals (253)
Rare diseases (381)
Real estate (5965)
Recruiting (67)
Regulatory (22512)
Reports (46)
Research institute (2350)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (132)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3624)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (34)
Vaccines (704)
Venture capitalists (41)
Weight loss (239)
Women's health (36)
Worklife (16)
Date
Today (157)
Last 7 days (934)
Last 30 days (2639)
Last 365 days (32989)
2025 (10814)
2024 (35465)
2023 (40357)
2022 (51465)
2021 (55991)
2020 (54429)
2019 (46946)
2018 (35377)
2017 (32490)
2016 (31930)
2015 (37949)
2014 (31729)
2013 (26767)
2012 (29001)
2011 (29673)
2010 (27734)
Location
Africa (750)
Alabama (53)
Alaska (7)
Arizona (235)
Arkansas (14)
Asia (38650)
Australia (6342)
California (6154)
Canada (2022)
China (531)
Colorado (271)
Connecticut (279)
Delaware (149)
Europe (83232)
Florida (914)
Georgia (208)
Idaho (57)
Illinois (541)
India (25)
Indiana (309)
Iowa (11)
Japan (164)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4597)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1745)
New Mexico (28)
New York (1753)
North Carolina (987)
North Dakota (8)
Northern California (2689)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1124)
South Carolina (23)
South Dakota (1)
Southern California (2313)
Tennessee (101)
Texas (907)
United States (23250)
Utah (182)
Virginia (146)
Washington D.C. (64)
Washington State (552)
West Virginia (3)
Wisconsin (54)
706,436 Results for "petvivo holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
February 12, 2025
·
3 min read
BioMidwest
PetVivo Reports Reports Fiscal 2024 Results
PetVivo Holdings, Inc., a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024.
June 28, 2024
·
10 min read
BioMidwest
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
PetVivo Holdings, Inc. announced that the Company has released the results of a clinical study conducted by Inotiv, Inc., a world-renowned independent clinical research organization, which examined the safety of intra-articular injections of collagen-elastin hydrogel microparticulates into the joints of cats.
February 7, 2024
·
4 min read
Press Releases
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor
January 27, 2025
·
7 min read
Business
PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
PetVivo Holdings, Inc. announces financial results for the three months ended September 30, 2023.
November 14, 2023
·
10 min read
Press Releases
Medpace Holdings, Inc. Reports First Quarter 2025 Results
April 22, 2025
·
17 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
·
3 min read
Press Releases
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
April 17, 2025
·
5 min read
BioMidwest
PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application
PetVivo Holdings, Inc. an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals is pleased to announce that the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company’s proprietary biocompatible protein-based particles.
August 17, 2023
·
3 min read
Press Releases
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
April 8, 2025
·
1 min read
1 of 70,644
Next
